TABLE 4

Standardized Effects of CDS on Adherence to Guidelines for AOM and OME During CDS-only Follow-up Period (Time 2, Months 13–23) Versus Baseline Period (Time 1, Months 1–12)

Adherence to guidelines metricsSample sizeCDS PracticesNon-CDS PracticesCDS Practices – Non-CDS Practices
Time 2 – Time 1Time 2 – Time 1Time 2 – Time 1
Percentage difference (P value)
Comprehensive care
 AOM56 1415.3 (<.001)0.9 (.417)4.4 (.006)
 OME67051.5 (.148)−1.0 (.084)2.5 (.032)
Pain treated16 28911.4 (<.001)5.7 (<.001)5.7 (.030)
AOM diagnostic evaluation69 4193.8 (.035)−0.9 (.786)4.6 (.214)
Amoxicillin as first-line therapy for AOM49 8215.0 (<.001)0.9 (.115)4.1 (.001)
High-dose amoxicillin for AOM36 1369.7 (<.001)3.5 (.329)6.2 (.142)
AOM treatment of penicillin-allergic patients3581−1.2 (.371)−0.9 (.782)−0.3 (.937)
AOM watchful waiting39 098<0.1 (.811)−0.7 (.207)0.8 (.211)
OME diagnostic evaluation16 1163.2 (.045)−1.8 (.058)5.0 (.008)
OME watchful waiting5560–3.2 (.033)−1.3 (.223)−1.8 (.323)